Full Schedule

Lead Speaker: Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands

Speaker: Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School

Lead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands

Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark

Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney

Speaker: Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University

Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden

Lead Speaker: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research

Speaker: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA

Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion

Lead Speaker: Priya Bahri, PhD – European Medicines Agency (EMA)

Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific

Speaker: Peter GM Mol, PhD PharmD (he/him/his) – Dutch Medicines Evaluation Board

Speaker: Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago

Speaker: Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson

Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Lead Speaker: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals

Speaker: Hope Mueller, Masters of Business – Currax Pharmaceuticals LLC

Speaker: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania

Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney

Speaker: Mary E. Ritchey, PhD, FISPE – CERobs Consulting

Speaker: Robert W. Platt, PhD (he/him/his) – McGill University

Speaker: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill

Lead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands

Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark

Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands

Speaker: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead

Speaker: Victoria Strauss, PhD – Boehringer Ingelheim

Speaker: Joseph W. Zabinski, PhD – OM1, Inc.

Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA

Lead Speaker: Geetha Iyer – Harvard T.H. Chan School of Public Health

Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson

Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

Speaker: Todd A. Miano, PharmD, PhD – University of Pennsylvania

Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany

Lead Speaker: Amalia M. Issa, PhD, MPH, FISPE

Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine

Speaker: Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration

Speaker: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals

Speaker: Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc.

Speaker: Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration

Speaker: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia

Speaker: Soko Setoguchi, MD, DrPH – Rutgers University

Lead Speaker: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine

Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy

Speaker: Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group

Speaker: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research

Speaker: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC